Compugen Stock

Compugen Cash Ratio

The Cash Ratio of Compugen (CGEN) as of Aug 13, 2026 is 6.99. In the previous year, Cash Ratio was 5.37 — a change of 30.03% (higher).

Cash Ratio

6.99

YoY

30.03%

Last updated:

Cash Ratio of Compugen is 2026 6.99 . Cash Ratio of Compugen was 2025 5.37 . It decreases by 30.03% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Cash Ratio of Compugen is 6.99 in 2026.

Cash Ratio of Compugen changed from 5.37 to 6.99, representing a 30.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Ratio Compugen since 2006 – with annual values, charts, and detailed analysis.

The Cash Ratio is the most conservative liquidity metric, comparing only cash and equivalents to current liabilities.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Ratio's Compugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Compugen

All Key Metrics — Compugen